CD3+, CD4+, and CD8+ T cell counts are significantly lower in patients with severe COVID-19 when compared to those with mild disease (57, 60, 133, 134, 153), with numbers increasing significantly in subjects who respond clinically to anti-viral treatment (133). This evidence concerns the gene CD8A and COVID-19.